Inventor · disambiguated record
Ian J. Mohr
Also filed as: MOHR IAN · MOHR IAN J
13 granted patents·2 pending applications·173 citations·filing 1990–2021
91Inventor score
Top patents by PatentIndex Score
15 records- 0196US7731952B2Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host responseUNIV NEW YORK·Filed 2005·Granted Jun 8, 2010·71 cites·13 claims
- 0291US10105404B2Oncolytic herpes simplex virus and therapeutic uses thereofUNIV NEW YORK·Filed 2017·Granted Oct 23, 2018·9 cites·40 claims
- 0386US8252277B2Virulent oncolytic herpes simplex virus strains engineered to counter the innate host responseMOHR IAN·Filed 2010·Granted Aug 28, 2012·6 cites·11 claims
- 0483US8709397B2Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host responseMOHR IAN·Filed 2012·Granted Apr 29, 2014·7 cites·12 claims
- 0581US9623059B2Oncolytic herpes simplex virus and therapeutic uses thereofMOHR IAN J·Filed 2012·Granted Apr 18, 2017·6 cites·64 claims
- 0679US5824318AAvirulent herpetic viruses useful as tumoricidal agents and vaccinesAMERICAN CYANAMID CO·Filed 1996·Granted Oct 20, 1998·54 cites·12 claims
- 0778US10456432B2Oncolytic herpes simplex virus and therapeutic uses thereofUNIV NEW YORK·Filed 2018·Granted Oct 29, 2019·1 cites·40 claims
- 0875US2022031779A1Oncolytic herpes simplex virus and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 0974US11147846B2Oncolytic herpes simplex virus and therapeutic uses thereofUNIV NEW YORK·Filed 2019·Granted Oct 19, 2021·0 cites·23 claims
- 1057US11944608B2Targeting RNA viruses using inhibitors of METTL3UNIV NEW YORK·Filed 2021·Granted Apr 2, 2024·0 cites·10 claims
- 1153US10967015B2Method of treatment using oncolytic virusesUNIV NEW YORK·Filed 2016·Granted Apr 6, 2021·0 cites·19 claims
- 1252US5464936ACompositions for identification of papillomavirus replication inhibitorsCETUS ONCOLOGY CORP·Filed 1990·Granted Nov 7, 1995·9 cites·4 claims
- 1349US2021164992A1Compositions and methods related to innate response to dna and regulation of interferon-betaUNIV NEW YORK·Filed 2019·Application pending·0 cites
- 1438US5620849AMethods and compositions for identifying inhibitors of papilloma virus replicationCETUS CORP·Filed 1994·Granted Apr 15, 1997·7 cites·7 claims
- 1537US5925516AMedicaments for the treatment of papillomavirus diseasesCHIRON CORP·Filed 1995·Granted Jul 20, 1999·3 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →